WTKE - Episode 74: Understanding the 340B Challenge: Policy, Impact, and the Path Forward

The 340B Drug Pricing Program is a decades-old federal program designed to support safety-net providers like MaineHealth in stretching scarce resources and expanding access to care. But in recent years, the 340B landscape has shifted dramatically.

From mounting legal challenges to restrictive contract pharmacy policies and changing manufacturer relationships, the program is under increasing pressure — with real consequences for health systems and the patients we serve.

In this new Working Together episode, MaineHealth Chief Operating Officer Kelly Elkins and Chief Pharmacy Officer Brian Marden unpack what’s happening in the 340B space nationally, how it’s affecting our organization locally, and what MaineHealth leaders are doing to respond — and advocate — for a sustainable path forward.